Latest News

Australian-Iranian Spikogen vaccine has been approved for emergency use in Iran

Spikogen vaccine is the result of a collaboration between Vaxine and CinnaGen, a private company with operations in the Middle East. The Iranian Food and Drug Administration (IFDA) has issued an emergency use authorisation for Spikogen vaccine. Plans are being made by the partners to expand approval to other countries. https://en.mehrnews.com/news/179432/Iran-issues-emergency-permit-for-new-local-Covid-19-vaccine

Efficacy of covid-19 vaccines (Video)

Amid the COVID-19 pandemic and the development of new vaccines, we hear the term “vaccine efficacy” more than ever. But, this raises some questions: what do these efficacy numbers exactly mean? How do the researchers calculate these numbers? And, how should these numbers be interpreted? Vaccine candidates undergo clinical trials to determine vaccine efficacy, and […]

Recent paper on use of our Advax-CpG adjuvant in Herpes Simplex virus Vaccine development

This latest paper highlights a Herpes simplex virus vaccine being developed in collaboration with our Swedish partners. The Advax-CpG adjuvant in this herpes simplex vaccine is the same approach as we are using in our current COVID-19 vaccine. Link to the paper:https://www.sciencedirect.com/science/article/pii/S0264410X21010987